This week, National Drug Screening, Inc. announced its recent accreditation by BBB Serving Central Florida. As a BBB Accredited Business, National Drug Screening, Inc. is dedicated to promoting trust in the marketplace and is committed to maintaining BBB\u2019s Standards of Trust.<\/p>\n\n\n\n
According to BBB reports by Princeton Research, seven in ten consumers say they are more likely to buy from a company designated as a BBB Accredited Business. BBB is a resource for the public, providing, providing objective, unbiased information about businesses.<\/p>\n\n\n\n
\u201cWe are pleased to be BBB Accredited because we value building trust with our customers,\u201d said Joe Reilly, President of National Drug Screening. \u201cOur BBB Accreditation gives our customers confidence in our commitment to maintaining high ethical standards of conduct.\u201d<\/p>\n\n\n\n
BBB Accredited Businesses must adhere to BBB\u2019s \u201cStandards of Trust,\u201d a comprehensive set of policies, procedures and best practices representing trustworthiness in the marketplace. The standards call for building trust, embodying integrity, advertising honestly and telling the truth, being transparent, honoring promises, being responsive and safeguarding privacy.<\/p>\n\n\n\n
About BBB<\/p>\n\n\n\n
BBB\u2019s mission is to be the leader in advancing marketplace trust. BBB accomplishes this mission by creating a community of trustworthy businesses, setting standards for marketplace trust, encouraging and supporting best practices, celebrating marketplace role models and denouncing substandard marketplace behavior.<\/p>\n\n\n\n
Businesses that earn BBB Accreditation contractually agree and adhere to the organization\u2019s high standards of ethical business behavior. BBB is the preeminent resource to turn to for objective, unbiased information on businesses and charities. Contact BBB Serving Central Florida at 407-786-9008.<\/p>\n\n\n\n
About National Drug Screening<\/p>\n\n\n\n
National Drug Screening (NDS) offers simple and compliant drug testing program management and result reporting through a state of the art, secure online software portal combined with a dedicated MRO services team. Our TPA Drug Testing Software includes scheduling of e-chain paperless drug tests for LabCorp, Quest, and FormFox enabled collection sites plus provides web based results reporting, online random program management, and electronic data management. Working with NDS, you also have access to a live, US based support team that actually answers your calls and promptly responds to emails. Ready to simplify your processes and improve your level of service? Contact the NDS team today and discover what we can do working together. Visit us at https:\/\/www.nationaldrugscreening.com\/ or contact Tom Fulmer or Joe Reilly at 866-843-4545.<\/p>\n","protected":false},"excerpt":{"rendered":"
This week, National Drug Screening, Inc. announced its recent accreditation by BBB Serving Central Florida. As a BBB Accredited Business, National Drug Screening, Inc. is dedicated to promoting trust in the marketplace and is committed to maintaining BBB\u2019s Standards of Trust. According to BBB reports by Princeton Research, seven in ten consumers say they are […]<\/p>\n","protected":false},"author":12,"featured_media":54124,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"51545,51240,50940,50866,50949,51000","_relevanssi_noindex_reason":"","footnotes":""},"categories":[76],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/51543"}],"collection":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/comments?post=51543"}],"version-history":[{"count":0,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/51543\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media\/54124"}],"wp:attachment":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media?parent=51543"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/categories?post=51543"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/tags?post=51543"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}